Gene expression signature of IKZF1 deleted B‐cell acute lymphoblastic leukaemia reveals a unique regulation of MUC4
British Journal of Haematology · 2025
DOI: 10.1111/bjh.70014 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Preity Sharma und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Oncology Unit, Dr BRA IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India. Hauptthemen laut MEDLINE: Ikaros Transcription Factor, Mucin-4, Gene Expression Regulation, Leukemic, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
The IKAROS ( IKZF1 ) transcription factor regulates the differentiation of pre‐B cells to mature B lymphocytes. The loss of IKZF1 expression has been linked with increased matrix adhesion along with increased expression of stemness markers that form a hallmark of B‐lymphoblasts. However, the spectrum of differentially regulated genes has not been investigated in detail in B‐cell acute lymphoblastic leukaemia (B‐ALL) patients expressing IKZF1 deletion. In this study, we analysed the gene expression signature of 24 B‐ALL patients with IKZF1 deletion against 32 B‐ALL patients with wild‐type IKZF1 . RNA sequencing revealed an adhesion signature corresponding to deregulation of MUC4 , secreted phosphoprotein 1 ( SPP1 ), LAMB3 , CLSTN2 and MERTK . The upregulation of MUC4 expression was further validated in a B‐ALL patient cohort. Moreover, by chromatin immunoprecipitation, we observed the direct binding of IKZF1 on MUC4 promoter and enhancer sequences. Thus, the increase in MUC4 expression upon IKZF1 deletion could be explained by a loss of IKZF1 repression on the MUC4 locus. Finally, using the TARGET‐ALL‐P2 database, we observed a correlation between decreased survival and high MUC4 expression in B‐ALL patients. Thus, we propose MUC4 expression as an indicator of patient prognosis that correlates with the loss of IKZF1 in B‐ALL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory Oncology Unit, Dr BRA IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
- Kusuma School of Biological Sciences, Indian Institute of Technology (IIT), New Delhi, India.
- Integrative Biology and Physiology Master, Faculty of Sciences and Engineering, Sorbonne Université, Paris, France.
- Department of Medical Oncology, Dr BRA IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
- Department of Biostatistics, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
ORCID-Profile: Sameer Bakhshi, Ritu Gupta, Smeeta Gajendra, Anita Roy, Sanjeev Kumar Gupta
Zitieren
APA
Sharma, P., Leons, G. K., Singh, V., Naseer, S., Ribeyron, L., Bakhshi, S., Gupta, R., Gajendra, S., Thoudam, D. S., Sarawat, S. K., Khan, M. A., Pushpam, D., Sahoo, R. K., Roy, A., & Gupta, S. K. (2025). Gene expression signature of IKZF1 deleted B‐cell acute lymphoblastic leukaemia reveals a unique regulation of MUC4. British Journal of Haematology. https://doi.org/10.1111/bjh.70014
Vancouver
Sharma P, Leons GK, Singh V, Naseer S, Ribeyron L, Bakhshi S, et al. Gene expression signature of IKZF1 deleted B‐cell acute lymphoblastic leukaemia reveals a unique regulation of MUC4. British Journal of Haematology. 2025. doi:10.1111/bjh.70014
BibTeX
@article{Sharma2025,
author = {Sharma, Preity and Leons, Gadha K and Singh, Vivek and Naseer, Saadia and Ribeyron, Louis and Bakhshi, Sameer and Gupta, Ritu and Gajendra, Smeeta and Thoudam, Debraj Singh and Sarawat, Surender Kumar and Khan, Maroof Ahmed and Pushpam, Deepam and Sahoo, Ranjit Kumar and Roy, Anita and Gupta, Sanjeev Kumar},
title = {Gene expression signature of IKZF1 deleted B‐cell acute lymphoblastic leukaemia reveals a unique regulation of MUC4},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.70014}
}
EUVIMED